Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|November 21, 2020
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancerPaul Johannet, Amelia Sawyers, Yingzhi Qian, et al.Atherosclerosis|November 19, 2019
Body mass index and peripheral artery diseaseSean P Heffron, Aeshita Dwivedi, Caron B Rockman, et al.Mayo Clinic Proceedings|July 23, 2018
Acute Myocardial Infarction During Pregnancy and the Puerperium in the United StatesNathaniel R Smilowitz, Navdeep Gupta, Yu Guo, et al.Cancer Medicine|October 14, 2021
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitorsNicholas Gulati, Arda Celen, Paul Johannet, et al.Seminars in Dialysis|October 31, 2020
Fragmentation of care as a barrier to optimal ESKD managementCaroline E Sloan, Judy Zhong, Dinushika Mohottige, et al.Human Pathology|June 4, 2014
Enhanced immunohistochemical detection of neural infiltration in primary melanoma: is there a clinical value?Patrick Scanlon, Jaiying Tian, Judy Zhong, et al.Diabetes, Obesity & Metabolism|July 27, 2018
Elevated GlycA in severe obesity is normalized by bariatric surgeryArun Manmadhan, Bing-Xue Lin, Judy Zhong, et al.Journal for Immunotherapy of Cancer|August 21, 2019
The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patientsDouglas Donnelly, Shirin Bajaj, Jaehong Yu, et al.Cancer|August 25, 2022
Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanomaPaul Johannet, Morgan Simons, Yingzhi Qian, et al.Journal of Translational Medicine|January 31, 2021
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patientsPaul Johannet, Amelia Sawyers, Nicholas Gulati, et al.Pageof 8